![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/18 | (2006.01) |
A61K 47/60 | (2017.08) | ||
A61P 3/10 | (2006.01) | ||
A61K 47/549 | (2017.08) | ||
A61P 9/10 | (2006.01) | ||
A61P 3/10 | (2018.01) | ||
A61P 17/00 | (2006.01) | ||
A61K 38/1825 | (2013.01) | ||
A61P 17/02 | (2006.01) | ||
A61P 27/02 | (2006.01) | ||
C07K 14/50 | (2006.01) | ||
C12P 21/00 | (2006.01) |
(11) | Number of the document | 3678687 |
(13) | Kind of document | T |
(96) | European patent application number | 18852510.9 |
Date of filing the European patent application | 2018-09-04 | |
(97) | Date of publication of the European application | 2020-07-15 |
(45) | Date of publication and mention of the grant of the patent | 2022-08-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2018/001112 |
Date | 2018-09-04 |
(87) | Number | WO 2019/043457 |
Date | 2019-03-07 |
(30) | Number | Date | Country code |
201762553970 P | 2017-09-04 | US |
(72) |
KOPEC, Karla, K. , US
LIU, Patrick, Mengyuan , US
|
(73) |
89Bio Ltd. ,
6 Hamada Street, 673340 Herzliya,
IL
|
(54) | MUTANT FGF-21 PEPTIDE CONJUGATES AND USES THEREOF |
MUTANT FGF-21 PEPTIDE CONJUGATES AND USES THEREOF |